John H. Hammergren - McKesson
Last quote by John H. Hammergren
May 18 2017
We can learn a lot about a person if we know what types of things he or she talks about or comments on the most frequently. There are numerous topics with which John H. Hammergren is associated, including McKesson and pricing. Most recently, John H. Hammergren has been quoted saying: “Although we were unfavorably impacted in the third quarter by weaker branded pharmaceutical pricing than anticipated, we are updating our fiscal 2017 outlook to reflect McKesson's lower full-year effective tax rate.” in the article Drug distributor McKesson to buy CoverMyMeds for $1.1 billion. An other article where John H. Hammergren has been quoted is McKesson in record $150 million U.S. settlement over suspicious drug orders.
Take our quote verification challenge and find out !
Quotes by John H. Hammergren
Jan 25 2017
Although we were unfavorably impacted in the third quarter by weaker branded pharmaceutical pricing than anticipated, we are updating our fiscal 2017 outlook to reflect McKesson's lower full-year effective tax rate.feedback
Jan 17 2017
We are committed to tackling this multi-faceted problem in collaboration with all parties in the supply chain that share the responsibility for the distribution of opioid medications.feedback
Jan 17 2017
We continue to significantly enhance the procedures and safeguards across our distribution network to help curtail prescription drug diversion while ensuring patient access to needed medications.feedback
Oct 28 2016
Our updated outlook for fiscal 2017 reflects McKesson's expectation of a lower profit contribution resulting from recent customer pricing activities and lower operating profit as a result of further moderating branded pharmaceutical pricing trends compared to previous expectations.feedback
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided